Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 USD | +3.77% | +6.45% | -33.33% |
May. 06 | Genenta Science S.p.A. Announces New Board Appointments | CI |
Apr. 08 | Genenta Science S.P.A. Announces Resignation of Board Members | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 55.52M 60.33M |
---|---|---|---|---|---|
Net income 2024 * | -18M -19.56M | Net income 2025 * | -24M -26.08M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.61
x | P/E ratio 2025 * |
-3.41
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.08% |
1 day | +3.77% | ||
1 week | +6.45% | ||
Current month | +7.14% | ||
1 month | -15.72% | ||
3 months | -25.34% | ||
6 months | -38.89% | ||
Current year | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Bernhard Gentner
FOU | Founder | - | 14-07-23 |
Luigi Naldini
FOU | Founder | - | 14-07-23 |
Chief Executive Officer | 50 | 14-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 62 | 21-05-19 |
Roger Abravanel
BRD | Director/Board Member | 77 | 21-05-19 |
Chief Executive Officer | 50 | 14-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.3 | +3.77% | 1,686 |
24-05-16 | 3.18 | -0.63% | 1,341 |
24-05-15 | 3.2 | -0.62% | 3,556 |
24-05-14 | 3.22 | -8.15% | 2,070 |
24-05-13 | 3.506 | +13.09% | 1,082 |
Delayed Quote Nasdaq, May 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.33% | 60.36M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- GNTA Stock